how were glp 1 agonists discovered Understanding GLP-1 receptor and their impact on drug discovery Discovery of novel glucagon-like peptide

GLP-1 medications, like semaglutide (Ozempic, Wegovy), were originally developed to help people with type 2 diabetes manage blood sugar

Although data on HR were not provided in most studies of twice-daily exenatide, HR elevation was generally more apparent in the GLP-1 RA treatment arms, compared with the comparator arms (Table 2)

Table 3 summarizes the PIONEER trial programmes [35,36,37,38,39,40,41,42,43,44]

In all five clinical trials (SURPASS trials), Tirzepatide was the only medication to lower body weight (5.411.7 kg) in T2D when given weekly at doses of 515 mg [298]

OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells